Abrocitinib shows sustained efficacy in treating moderate to severe AD across multiple clinical and patient-reported outcome measures.

An expert discusses how rilzabrutinib uniquely improves quality-of-life metrics, including fatigue and women’s health domains, which previous immune thrombocytopenia (ITP) therapies failed to address ...

The pretreatment evaluation of patient-reported, health-related quality of life provides valuable prognostic information on ...

Experts discuss the challenges of managing atopic dermatitis in real-world clinical practice, highlighting access barriers due to insurance disparities, the need for creative solutions to provide ...

Please provide your email address to receive an email when new articles are posted on . In business, the focus on consistent outcomes includes managing “inputs,” such as uniform materials and ...

Generally, patient-reported outcomes (PROs) provide complementary information to measured or clinician-assessed functions or symptoms. First, PROs need to be tailored to the specific disorder and, ...

The SISAQOL-IMI consortium, co-led by the European Organization for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), has published a paper in The Lancet Oncology outlining how ...

Implementation of an electronic patient-recorded outcome (ePRO) monitoring system improves patient-physician communication in cardiovascular care, according to a study published online Jan. 14 in JAMA ...

Real-world assessment of treatment-related symptoms and associated burden among African American and Caucasian patients receiving chemotherapy in the US. Impact of clinical response and AEs on ...

Please provide your email address to receive an email when new articles are posted on . Historically, patient-reported outcome measures were primarily used for research. Today, surgeons use ...